VivoSim Labs, INC.

VIVS Nasdaq SEC CIK 1497253
Follow VivoSim Labs Weekly email: filings, results

Financials

Reported figures only · latest: Q2 2027 USD · US GAAP
Revenue, last quarter $51K +82.1% vs same quarter last year
Net income −$475K +81.3% vs same quarter last year
EPS, diluted −$0.03 +96.9% vs same quarter last year
Operating cash flow −$2.5M −4.2% vs same quarter last year
Revenue by quarter
$24K
$51K
$37K
$28K
$26K
$40K
$18K
$51K
Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27 Q2 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$60M−$40M−$20M$0$20MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26$131K−$13.8M
FY25$144K−$2.5M
FY24$109K−$14.7M
FY23$370K−$17.3M
FY22$1.5M−$11.4M
FY21$0−$16.8M
FY20$2.2M−$18.7M
FY19$3.1M−$26.6M
FY18$4.6M−$34.8M
FY17$4.2M−$38.4M
FY16$1.5M−$38.6M
FY15$571K−$30.1M
FY14$379K−$25.8M
FY13$1.2M−$43.6M
FY12$969K−$4.4M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−15000%−10000%−5000%0%5000%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearGross marginOperating marginNet margin
FY26100%−8768.7%−10567.2%
FY2596.5%−8761.1%−1727.8%
FY24-−13840.4%−13459.6%
FY23-−4792.2%−4664.6%
FY22-−765.3%−763.2%
FY21---
FY2086.3%−977.9%−852%
FY1983.8%−882.4%−861.7%
FY1878.3%−766.3%−756.1%
FY1777.4%−911.9%−908.9%
FY16100%−2605.7%−2601.1%
FY15100%−5306%−5268.3%
FY14-−5448.3%−6820.1%
FY13-−778.5%−3638.5%
FY1287.5%−237.9%−452.3%
Free cash flowOperating cash flow minus capital expenditure
−$40M−$30M−$20M−$10M$0FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearFree cash flow
FY26−$10.8M
FY25−$9.5M
FY24−$14.7M
FY23−$12.8M
FY22−$8.9M
FY21−$13.7M
FY20−$14.9M
FY19−$20.5M
FY18−$29.1M
FY17−$30.5M
FY16−$31.5M
FY15−$21.1M
FY14−$15.8M
FY13−$10.1M
FY12−$2M
Returned to shareholdersDividends paid and shares bought back
$0$250$500$750$1KFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearBuybacks
FY26-
FY25-
FY24-
FY23-
FY22$0
FY21$1K
FY20$0
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • VivoSim Labs
  • Healthcare median
−15000%−10000%−5000%0%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearVivoSim LabsHealthcare median
FY26−10567.2%−11.1%
FY25−1727.8%−30.6%
FY24−13459.6%−47%
FY23−4664.6%−58%
FY22−763.2%−80.4%
FY21-−71.8%
FY20−852%−62.2%
FY19−861.7%−46.2%
FY18−756.1%−49.6%
FY17−908.9%−45.9%
FY16−2601.1%−36%
FY15−5268.3%−37.8%
FY14−6820.1%−35.5%
FY13−3638.5%−37.1%
FY12−452.3%−29.1%